Difference between revisions of "Part:BBa K4256166:Design"
SunJi UCAS (Talk | contribs) (→Source) |
|||
Line 13: | Line 13: | ||
===Source=== | ===Source=== | ||
− | It comes from the combination of composite parts | + | It comes from the combination of composite parts BBa_I712074, BBa_K1222999, BBa_K3716001, BBa_K4256122 and BBa_B0012, and the source of each part can be checked. |
===References=== | ===References=== |
Latest revision as of 17:36, 11 October 2022
ccdB toxin expression system
Assembly Compatibility:
- 10INCOMPATIBLE WITH RFC[10]Illegal XbaI site found at 158
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BamHI site found at 119
- 23INCOMPATIBLE WITH RFC[23]Illegal XbaI site found at 158
- 25INCOMPATIBLE WITH RFC[25]Illegal XbaI site found at 158
- 1000COMPATIBLE WITH RFC[1000]
Design Notes
BamHI is added before the ccdB sequence while HindIII is added after the ccdB sequence to facilitate separate vector concatenation and enzymatic identification recovery afterward, but there are no these two enzymatic sites in the whole sequence. The uploaded BBa_K4256166 sequence contains a lactose manipulator-related sequence to facilitate IPTG induction during experiments, but the full sequence for practical applications does not contain a lac operon or can be enzymatically excised away.
Source
It comes from the combination of composite parts BBa_I712074, BBa_K1222999, BBa_K3716001, BBa_K4256122 and BBa_B0012, and the source of each part can be checked.